Carvedilol phosphate, alpha1and beta1, beta2blocker (ab143592)

Overview

  • Product name

    Carvedilol phosphate, alpha1and beta1, beta2blocker
  • Description

    Nonselective beta (β1, β2) blocker and alpha (α1) blocker
  • Biological description

    Nonselective beta (β1, β2) blocker and alpha (α1) blocker. Inhibits LDL oxidation (IC50 = 3.8 μM). Shows negative chronotropic effects in vivo. Moderately orally active.
  • Purity

    > 98%
  • CAS Number

    610309-89-2
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Yamaura S  et al. Effect of chronic hypoxic hypoxia on oxidation and glucuronidation of carvedilol in rats. Eur J Drug Metab Pharmacokinet 39:53-9 (2014). Read more (PubMed: 23739952) »
  • Chakraborty S  et al. Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate. J Pharm Pharmacol 63:774-9 (2011). Read more (PubMed: 21585374) »
  • Liu T & Li G Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation. Int J Cardiol 145:140-2 (2010). Read more (PubMed: 19616323) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab143592.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up